These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4028299)

  • 1. Salivary excretion of 5-fluorouracil. I. Fluctuation of the saliva/plasma concentration ratio and salivary clearance in beagle dogs following bolus intravenous administration.
    Watanabe J; Hayashi Y; Iwamoto K; Ozeki S
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1187-94. PubMed ID: 4028299
    [No Abstract]   [Full Text] [Related]  

  • 2. Salivary excretion of 5-fluorouracil. II. Fluctuation of saliva/plasma concentration ratio and salivary clearance during a constant rate intravenous infusion in beagle dogs.
    Hayashi Y; Watanabe J; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1988 Jun; 11(6):438-43. PubMed ID: 3171885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary excretion of 5-fluorouracil (5-FU). IV. Dependency of saliva/plasma concentration ratio and salivary clearance on plasma concentration of 5-FU during constant-rate intravenous infusion in rats.
    Hayashi Y; Watanabe J; Ozeki S
    J Pharmacobiodyn; 1989 Mar; 12(3):137-44. PubMed ID: 2760793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary excretion of 5-fluorouracil (5-FU). III. Non-linear kinetics of salivary excretion of 5-FU following bolus intravenous administration in rats.
    Hayashi Y; Watanabe J; Ozeki S; Iwamoto K
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4547-53. PubMed ID: 3246024
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of indomethacin into saliva following intravenous administration to dogs.
    Watanabe J; Urasaki Y; Nakase Y; Ueda H; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 May; 4(5):336-44. PubMed ID: 7288551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of route of administration of 5-fluorouracil on its concentration in blood and lymph.
    Thomas M
    Br J Cancer; 1978 Jan; 37(1):105-8. PubMed ID: 619953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary excretion of urea in dogs.
    Watanabe J; Mizuno S; Masuda N; Hayashi Y; Iwamoto K; Hirate J; Ozeki S
    J Pharmacobiodyn; 1984 May; 7(5):294-303. PubMed ID: 6470927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein binding effects of salivary excretion of phenobarbital in dogs.
    Watanabe J; Nakase Y; Urasaki Y; Hayashi Y; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 Dec; 4(12):968-77. PubMed ID: 7341753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary excretion of N-nitrosodimethylamine in dogs.
    Hino K; Karaki Y; Hatanaka T; Sakamoto T; Tsukada K
    Eur J Cancer Prev; 2000 Aug; 9(4):275-81. PubMed ID: 10958331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary excretion of mexiletine after bolus intravenous administration in rats.
    Nagasako S; Hayashibara M; Katagiri Y; Iwamoto K
    J Pharm Pharmacol; 1992 Jan; 44(1):55-7. PubMed ID: 1350630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary passage of 5-fluorouracil during continuous infusion.
    Milano G; Thyss A; Santini J; Frenay M; Francois E; Schneider M; Demard F
    Cancer Chemother Pharmacol; 1989; 24(3):197-9. PubMed ID: 2736710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva.
    Celio LA; DiGregorio GJ; Ruch E; Pace J; Piraino AJ
    Eur J Clin Pharmacol; 1983; 24(2):261-6. PubMed ID: 6840177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent salivary excretion following bolus intravenous administration of lithium in dog.
    Watanabe J; Murata H; Higuchi J; Hayashi Y; Iwamoto K; Yuasa H; Ozeki S
    Chem Pharm Bull (Tokyo); 1988 Aug; 36(8):3105-12. PubMed ID: 3240517
    [No Abstract]   [Full Text] [Related]  

  • 14. Inter-organ relation between salivary gland and kidney in lithium excretion. I. Effects of continuous stimulation of salivation on salivary, renal and systemic clearances of lithium in dog.
    Watanabe J; Higuchi J; Hayashi Y; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1988 Dec; 11(12):801-7. PubMed ID: 3254978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary excretion of warfarin in rabbits: relationship between pharmacological effect and salivary pharmacokinetics of warfarin in rabbits.
    Sakai K; Nishiura A; Fujihara Y; Kutsuna T; Nishino T
    J Pharmacobiodyn; 1983 Dec; 6(12):991-9. PubMed ID: 6674482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dependency of salivary excretion of mexiletine on the plasma concentration in rats.
    Nagasako S; Iwamoto K; Hayashibara M; Katagiri Y
    J Pharm Pharmacol; 1993 Feb; 45(2):154-6. PubMed ID: 8095536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil concentrations in rat plasma, parotid saliva, and bile and protein binding in rat plasma.
    Celio LA; DiGregorio GJ; Ruch E; Pace JN; Piraino AJ
    J Pharm Sci; 1983 Jun; 72(6):597-9. PubMed ID: 6875817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear pharmacokinetic models for 5-fluorouracil in man: intravenous and intraperitoneal routes.
    Collins JM; Dedrick RL; King FG; Speyer JL; Myers CE
    Clin Pharmacol Ther; 1980 Aug; 28(2):235-46. PubMed ID: 7398191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [5-Fluorouracil-2 C14 distribution and its regional introduction into the gastric artery (experimental study)].
    Gasparian SA; Alimov AT; Itin AB
    Vestn Akad Med Nauk SSSR; 1968; 23(6):64-8. PubMed ID: 5746012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.